ATLASense Biomed
Sector: Healthcare & Life Sciences
About ATLASense Biomed
Meet REPHAEL, the world’s first predictive wearable for hospital at home REPHAEL doesn’t just monitor – it predicts, detects, and alerts
Products
Rephael
Continuous monitoring with proactive alerts to make safe, remote clinical decisions with enough reaction time to prevent clinical emergencies before they occur. The REPHAEL includes the following products: Basic Premium as addition to the BASIC version Real-time Continuous Cardiac Holter Monitoring HFL – Heart Functionality Level RII – Respiratory Insufficiency Index ESS – Early Screening for Sepsis FRD – Fall Risk Detection REPHAEL provides a broader range of clinical parameters than any other device, including cardiovascular, pulmonary, movement, temperature, and environmental metrics—all integrated into a single, synchronized system. It empowers doctors and nurses to make informed and safe clinical decisions by analyzing multiple physiological parameters and their trends over time. This ensures that no critical events are overlooked, while continuously monitoring all clinical parameters and generating proactive alerts for timely intervention.
Latest Company Updates
- Revolutionizing Elderly Care: How REPHAEL’s Remote Monitoring Transforms ER Discharge to Safe, Cost-Effective Home Care
- Transforming Patient Care with Continuous Monitoring: From ER Admission to Home Follow-Up
- ATLASense Biomed Awarded Prestigious Israeli Innovation Authority Grant to Advance Predictive Analytics for Early Sepsis Screening, in Collaboration with Prometheus
- ATLASense Biomed Awarded Grant from the Israel Innovation Authority to Develop Breakthrough Technology for Predicting Respiratory Deterioration
- AI-Driven Care: How REPHAEL Brings ICU-Level Precision Anywhere, Anytime